1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
637FAF652BF2CD62400258C37004CC740
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/37FAF652BF2CD62400258C37004CC740?OpenDocument
18
19OpenDocument
2018.97.14.90
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Medical Communication

Document Excerpt: Effective Oncology (Hematologic Malignancies) Medical Insights Management: Tools, Activities, and Training

DB Image

ID: MD-952


Features:

8 Info Graphics

46 Data Graphics

980+ Metrics

2 Narratives


Pages/Slides: 4


Published: 2025


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5852 “Effective Oncology (Hematologic Malignancies) Medical Insights Management: Tools, Activities, and Training”.

Industries Profiled:
Pharmaceutical; Communications; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Health Care; Chemical


Companies Profiled:
Agios; ApotheCom; Bayer; Boehringer Ingelheim; Eli Lilly and Company; Daiichi Sankyo; Eisai; Genentech; Janssen; Merck; Novartis; Roche; Sanofi Genzyme; Sandoz; Servier; Takeda Pharmaceuticals; Terumo BCT: Terumo Blood and Cell Technologies

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.